Freshfields Bruckhaus Deringer has advised ViGeneron GmbH on the deal. ViGeneron GmbH, a next-generation gene therapy company, agreed for a target-specific strategic collaboration and option agreement with...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb and Walder Wyss represented International Flavors & Fragrances in the transaction. Clifford Chance advised Citi. Freshfields has advised LANXESS. International Flavors & Fragrances (IFF)...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer advised Vivoryon Therapeutics N.V. Vivoryon Therapeutics N.V., a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines, signed a strategic regional licensing...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer advised Cheplapharm Arzneimittel GmbH on the deal, Cheplapharm Arzneimittel GmbH (‘Cheplapharm’) signed an agreement with Astellas Pharma Inc., a Japan based pharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer advised Ewopharma on the deal. Ewopharma, a pharmaceutical marketing organization based in Schaffhausen, Switzerland, signed a licensing agreement for two compounds/new chemical entities...
You must be a Standard 1 Year member to access this content.
